Royal Society of Chemistry, Biomaterials Science, 6(8), p. 1575-1579, 2020
DOI: 10.1039/c9bm02088h
Full text: Unavailable
We engineered a human epidermal growth factor receptor 2 (HER2) affibody to the surface of cell membrane nanovesicles (A-NVs) in a ligand-oriented manner and loaded them with indocyanine green (ICG) as precision theranostics for PHCC treatment.